NCT05015439View on ClinicalTrials.gov

Cannabidiol (CBD) in Adults With ASD

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Cannabidiol

The study intervention will be supplied as a softgel capsule containing cannabidiol.

DRUG

Placebo

The study intervention will be supplied as a softgel capsule containing inert filler.

Trial Locations (1)

21224

RECRUITING

JHBMC, Baltimore

All Listed Sponsors
collaborator

Charlotte's Web, Inc

INDUSTRY

lead

Johns Hopkins University

OTHER